Burgus, R. C. (Wayne State University, Detroit, Mich.), J. B. Hufham, W. M. Scott, and J. J. Pfiffner. Microbial degradation of corrinoids. III. Pigments derived from vitamin B(12) by Pseudomonas rubescens. J. Bacteriol. 88:1139-1144. 1964.-Products derived from vitamin B(12) by Pseudomonas rubescens under anaerobic conditions were examined. After incubation of the organism in broth containing Co(57)- or P(32)- vitamin B(12), electrophoresis of the extracted corrinoids yielded two major, yellow, radioactive fractions, designated A and B, with spectral and electrophoretic properties similar to pigments I and II, derived from vitamin B(12) by Aerobacter aerogenes. Fractions A and B were essentially inactive in promoting the growth of Lactobacillus leichmannii. Chromatography on carboxymethylcellulose separated both fractions A and B into four yellow, radioactive fractions. The absorption spectrum of each of the major subfractions showed a maximum in the ultraviolet region characteristic of a 5,6-dimethylbenzimidazole nucleotide, but lacked a maximum in the 360-mmu region characteristic of vitamin B(12) and many of its analogues and derivatives. The pigments were stable to cyanide and, although they were more stable to air and light than were the vitamin B(12) coenzymes and coenzyme analogues, they were apparently slowly decomposed by light. The data suggest that the bacteria alter the corrin nucleus of vitamin B(12).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314864 | PMC |
http://dx.doi.org/10.1128/jb.88.4.1139-1144.1964 | DOI Listing |
Exp Ther Med
February 2025
Department of Hematology, Etlik City Hospital, Ankara 06170, Turkey.
Whilst severe liver dysfunction is rarely encountered at the time of diagnosis for patients with acute myeloid leukemia (AML), mild elevations aminotransferase (<5 times the upper limit of normal) may be more frequently seen. Liver dysfunction at the time of diagnosis of AML is a parameter that requires investigation and can assist the clinicians in predicting prognosis. The aim of the present study was to investigate liver dysfunction at the time of diagnosis using the assoicated parameters in patients with AML.
View Article and Find Full Text PDFCureus
December 2024
Division of Internal Medicine, Unidade Local de Saúde de Braga, Braga, PRT.
Autoimmune polyglandular syndrome type 3 (APS-3) is an uncommon condition marked by autoimmune thyroid disease (ATD) linked with other autoimmune issues, excluding Addison's disease. We report a case of a 41-year-old man who was hospitalized due to exhaustion and macrocytic anemia, later diagnosed with APS-3, which included Hashimoto's thyroiditis, pernicious anemia resulting from autoimmune gastritis, and pre-existing vitiligo. Diagnostic results indicated positive intrinsic factor antibodies, a gastric biopsy compatible with gastritis, elevated thyroid peroxidase antibodies, and significant findings from a thyroid ultrasound.
View Article and Find Full Text PDFNeurol Res Pract
January 2025
Department of Vascular Neurology, University Hospital Bonn, Bonn, Germany.
Background: Nitrous oxide (N₂O), commonly known as laughing gas, is widely recognized for its anesthetic and analgesic effects, and is frequently used in medical contexts. However, its misuse can lead to significant neurological complications, which are often under-recognized in clinical practice. Recent data on such cases in Germany are rare.
View Article and Find Full Text PDFPediatr Res
January 2025
Department of Neurology, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China.
Background: CblC type methylmalonic aciduria (cblC disease) is the most common inborn error of vitamin B12 metabolism and due to mutations in the MMACHC gene. The earlier the diagnosis, the better the prognosis. Therefore, convenient and inexpensive detection method is needed.
View Article and Find Full Text PDFJ Neurol
January 2025
Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Background: Neurologic symptoms seen in patients receiving immune checkpoint inhibitors (ICI) may not be entirely caused by immunotoxicity. We aim to highlight these confounding conditions through clinical cases to encourage early recognition and management.
Methods: We describe a series of seven cases from our institution that were treated with ICI and presented with Neurologic symptoms and were diagnosed with superimposed conditions beyond immunotoxicity.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!